Wegovy 2,4 mg

Winkelwagen

Thuis
Afrekenen
Winkel
0Wishlist
  1. Thuis
  2. Verlies van het gewicht
Vorig
Dexamfetamine Tentin 5 mg
Dexamfetamine Tentin 5 mgHuidige prijs: €80. Oorspronkelijke prijs was: €90.
Volgende
Ozempic 2mg€170
Ozempic 2mg
Wegovy 2,4 mg

Wegovy 2,4 mg

Sold: 0

€180

Wegovy 2,4 mg vertegenwoordigt een krachtig instrument in de strijd tegen obesitas, ondersteund door de wetenschap en in de echte wereld succes. Als u klaar bent om de controle van uw gewicht, praten met een professional uit de gezondheidszorg vandaag de dag om te verkennen of dit medicijn voor u geschikt is. Vergeet niet, duurzame verandering komt van weloverwogen keuzes en voortdurende support.

Wegovy 2,4 mg

€180

Toevoegen aan winkelwagen
Nu Kopen
Categorie: Tag:

Product Beschrijving

Wegovy 2,4 mg

Wegovy 2.4 mg (semaglutide) is an FDA-approved prescription injectable medication designed for chronic weight management in adults with obesity or overweight conditions accompanied by weight-related medical issues. Representing the maximum therapeutic maintenance dose, Wegovy 2.4 mg is administered once weekly alongside a reduced-calorie meal plan and increased physical activity to support long-term weight loss.

How Wegovy 2.4 mg Works

Wegovy belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide mimics the naturally occurring GLP-1 hormone produced in the intestines, directly targeting areas of the brain that regulate appetite and food intake.

  • Satiety Enhancement: Promotes a feeling of fullness after meals, reducing overall caloric intake and cravings.

  • Delayed Gastric Emptying: Slows the rate at which food leaves the stomach, helping maintain fullness longer.

  • Cardiovascular Benefits: Reduces the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity.

Dosing and Administration Guidelines

Wegovy 2.4 mg is the final maintenance dose reached after a gradual dose-escalation schedule designed to minimize gastrointestinal side effects.

Key Parameter Clinical Recommendation
Beheer Subcutaneous injection into the abdomen, thigh, or upper arm once weekly.
Plannen Administer on the same day each week, at any time of day, with or without food.
Dose Progression Reached after completing 16 weeks of step-up dosing (0.25 mg to 1.7 mg).

Note: Never increase your dosage or alter your administration schedule without explicit medical supervision from your healthcare provider.

Potential Side Effects and Safety Warnings

While Wegovy 2.4 mg demonstrates strong clinical efficacy for weight loss, awareness of potential side effects and health precautions is essential.

Vaak Voorkomende Bijwerkingen

  • Nausea, vomiting, and diarrhea

  • Constipation, stomach pain, and heartburn

  • Fatigue, headache, and dizziness

  • Mild injection site reactions

Serious Warnings and Precautions

  • Thyroid Tumor Risk: Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • Acute Pancreatitis: Monitor for persistent, severe abdominal pain that radiates to the back.

  • Hypoglycemia Risk: Increased risk of low blood sugar when used in combination with insulin secretagogues or insulin.

Top
Top